125 related articles for article (PubMed ID: 8618622)
21. Drug resistance or tolerance in schistosomes?
Coles GC
Trends Parasitol; 2002 Jul; 18(7):294. PubMed ID: 12379947
[No Abstract] [Full Text] [Related]
22. [Low effectiveness of an oxamniquine and praziquantel combination in the therapy of schistosomiasis mansoni].
Dietze R; Prata A
Rev Soc Bras Med Trop; 1986; 19(4):247-9. PubMed ID: 3150592
[No Abstract] [Full Text] [Related]
23. [Drug therapy of mansoni schistosomiasis].
Zeitune JM; Ramos SR; Sugmyama LC; Côrte AA
Arq Gastroenterol; 1980; 17(2):88-95. PubMed ID: 7213141
[TBL] [Abstract][Full Text] [Related]
24. Schistosomiasis: new therapies for an old disease.
Imperato PJ
N Y State J Med; 1983; 83(11-12):1147-8. PubMed ID: 6358968
[No Abstract] [Full Text] [Related]
25. The chemotherapy of schistosomiasis control.
Bull Pan Am Health Organ; 1986; 20(1):68-9. PubMed ID: 3768593
[No Abstract] [Full Text] [Related]
26. Efficacy of oxamniquine, praziquantel and a combination of both drugs in schistosomiasis mansoni in Brazil.
Zwingenberger K; Queiroz JA; Poggensee U; Alencar JE; Valdegunas J; Esmeralda F; Feldmeier H
Rev Inst Med Trop Sao Paulo; 1987; 29(5):305-11. PubMed ID: 3136533
[No Abstract] [Full Text] [Related]
27. Survey on the clinical trial results achieved in Brazil comparing praziquantel and oxamniquine in the treatment of mansoni schistosomiasis.
de Rezende GL
Rev Inst Med Trop Sao Paulo; 1985; 27(6):328-36. PubMed ID: 3939162
[No Abstract] [Full Text] [Related]
28. Field trials of praziquantel and oxamniquine for the treatment of schistosomiasis mansoni in Burundi.
Gryseels B; Nkulikyinka L; Coosemans MH
Trans R Soc Trop Med Hyg; 1987; 81(4):641-4. PubMed ID: 3127965
[TBL] [Abstract][Full Text] [Related]
29. Double-blind therapeutical evaluation based on the quantitative oogram technique, comparing praziquantel and oxamniquine in human schistosomiasis mansoni.
da Cunha AS; Pedrosa RC
Rev Inst Med Trop Sao Paulo; 1986; 28(5):337-51. PubMed ID: 3109000
[No Abstract] [Full Text] [Related]
30. Testicular schistosomiasis simulating malignancy.
Lopes RI; Lopes RN; Leite KR; Prando D
Lancet Infect Dis; 2003 Sep; 3(9):556. PubMed ID: 12954561
[No Abstract] [Full Text] [Related]
31. The immune-dependence of chemotherapy in experimental schistosomiasis.
Doenhoff MJ
Mem Inst Oswaldo Cruz; 1989 Oct; 84 Suppl 1():31-7. PubMed ID: 2517867
[TBL] [Abstract][Full Text] [Related]
32. Randomized comparative trials of single doses of the newer antischistosomal drugs at Mwanza, Tanzania. I. Praziquantel and oxamniquine for the treatment of schistosomiasis mansoni.
Rugemalila JB; Asila J; Chimbe A
J Trop Med Hyg; 1984 Dec; 87(6):231-5. PubMed ID: 6398833
[TBL] [Abstract][Full Text] [Related]
33. Influence of specific treatment on the morbidity of Schistosomiasis mansoni in an endemic area of Minas Gerais, Brazil.
Conceicao MJ; Borges-Pereira J
Mem Inst Oswaldo Cruz; 2002 Jul; 97(5):755-7. PubMed ID: 12219148
[TBL] [Abstract][Full Text] [Related]
34. A new approach to the treatment of acute schistosomiasis.
Lambertucci JR
Mem Inst Oswaldo Cruz; 1989 Oct; 84 Suppl 1():23-30. PubMed ID: 2517865
[TBL] [Abstract][Full Text] [Related]
35. Specific schistosomiasis treatment as a strategy for disease control.
Coura JR; Conceição MJ
Mem Inst Oswaldo Cruz; 2010 Jul; 105(4):598-603. PubMed ID: 20721513
[TBL] [Abstract][Full Text] [Related]
36. The influence of anti-parasitic therapy on the course of the glomerulopathy associated with Schistosomiasis mansoni.
Martinelli R; Pereira LJ; Rocha H
Clin Nephrol; 1987 May; 27(5):229-32. PubMed ID: 3109794
[TBL] [Abstract][Full Text] [Related]
37. [Schistosomiasis mansoni simulating bladder neoplasia].
Lopes EJ; dos Santos TC; Martins V
Rev Soc Bras Med Trop; 2006; 39(3):287-8. PubMed ID: 16906256
[TBL] [Abstract][Full Text] [Related]
38. Effect of adamantylamide dipeptide on reinfection resistance after primary infection eradication in experimental Schistosomiasis mansoni.
Botros S; Mahmoud S; Hassan S; Ibrahim A; Zidek Z; Masek K
Arzneimittelforschung; 1996 Jan; 46(1):74-8. PubMed ID: 8821522
[TBL] [Abstract][Full Text] [Related]
39. Drugs for the control of parasitic diseases: current status and development in schistosomiasis.
Fenwick A; Savioli L; Engels D; Robert Bergquist N; Todd MH
Trends Parasitol; 2003 Nov; 19(11):509-15. PubMed ID: 14580962
[No Abstract] [Full Text] [Related]
40. Therapeutic effect of praziquantel enantiomers in mice infected with Schistosoma mansoni.
Xiao S; Chollet J; Booth M; Weiss NA; Tanner M
Trans R Soc Trop Med Hyg; 1999; 93(3):324-5. PubMed ID: 10492771
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
